Why minocycline is helpful in Huntington's disease

被引：16

作者：

Bonelli, RM ^{[1
]}

Kapfhammer, HP ^{[1
]}

机构：

[1] Karl Franzens Univ Graz, Univ Clin Psychiat, A-8036 Graz, Austria

来源：

JOURNAL OF PSYCHOPHARMACOLOGY | 2003年 / 17卷 / 04期

关键词：

D O I：

10.1177/0269881103174008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：461 / 461

页数：1

共 11 条

[1] Minocycline for the treatment of rheumatoid arthritis [J].

Alarcon, GS .

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) :489-+

[2] Minocycline slows progress of Huntington's disease in mice [J].

Berger, A .

BRITISH MEDICAL JOURNAL, 2000, 321 (7253) :70-70

[3] Minocycline for Huntington's disease: An open label study [J].

Bonelli, RM ;

Heuberger, C ;

Reisecker, F .

NEUROLOGY, 2003, 60 (05) :883-884

[4] Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease [J].

Chen, M ;

Ona, VO ;

Li, MW ;

Ferrante, RJ ;

Fink, KB ;

Zhu, S ;

Bian, J ;

Guo, L ;

Farrell, LA ;

Hersch, SM ;

Hobbs, W ;

Vonsattel, JP ;

Cha, JHJ ;

Friedlander, RM .

NATURE MEDICINE, 2000, 6 (07) :797-+

[5] Maintained improvement with minocycline of a patient with advanced Huntington's disease [J].

Denovan-Wright, EM ;

Devarajan, S ;

Dursun, SM ;

Robertson, HA .

JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (04) :393-394

[6] Benefits and risks of minocycline in rheumatoid arthritis [J].

Langevitz, P ;

Livneh, A ;

Bank, I ;

Pras, M .

DRUG SAFETY, 2000, 22 (05) :405-414

[7] Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease [J].

Ona, VO ;

Li, MW ;

Vonsattel, JPG ;

Andrews, LJ ;

Khan, SQ ;

Chung, WM ;

Frey, AS ;

Menon, AS ;

Li, XJ ;

Stieg, PE ;

Yuan, JY ;

Penney, JB ;

Young, AB ;

Cha, JHJ ;

Friedlander, RM .

NATURE, 1999, 399 (6733) :263-267

[8] Oral and systemic effects of prolonged minocycline therapy [J].

Patel, K ;

Cheshire, D ;

Vance, A .

BRITISH DENTAL JOURNAL, 1998, 185 (11-12) :560-562

[9] Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia [J].

Tikka, TM ;

Koistinaho, JE .

JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7527-7533

[10] Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease [J].

Yamamoto, A ;

Lucas, JJ ;

Hen, R .

CELL, 2000, 101 (01) :57-66

← 1 2 →